Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma

NCT: NCT07802769 · RECRUITING

NCT IDNCT07802769
StatusRECRUITING
Start Date2026-08-28
Completion2027-05
SponsorUniversity Hospital, Bordeaux (OTHER)
First posted
Last updated

Brief Summary

The EVOLUTION is a 10-year extension of the ENVOL study. It seeks to compare the evolution of structural and functional connectivity (Hub Disruption Index) and cerebral volume on 3T MRI of the brain in glaucoma patients and matched controls. The study aims to examine the hypothesis that glaucomatous optic neuropathy is not limited solely to the visual pathway, but rather is associated with a broader degeneration of the central nervous system.

Frequently Asked Questions

What is Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma?

Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma is a clinical trial registered under NCT07802769. Current status: RECRUITING.

What is the status of NCT07802769?

The current status of NCT07802769 (Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma) is: RECRUITING.

When did Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma start?

Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma started on 2026-08-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑